TROMBINI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 1.351
EU - Europa 584
AS - Asia 210
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 2.151
Nazione #
US - Stati Uniti d'America 1.329
DE - Germania 136
CN - Cina 112
SE - Svezia 102
IE - Irlanda 90
UA - Ucraina 76
SG - Singapore 51
IT - Italia 50
RU - Federazione Russa 44
GB - Regno Unito 43
FI - Finlandia 23
CA - Canada 22
HK - Hong Kong 22
IN - India 14
FR - Francia 4
VN - Vietnam 4
BE - Belgio 3
BR - Brasile 2
ES - Italia 2
IR - Iran 2
MD - Moldavia 2
NL - Olanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
ID - Indonesia 1
NG - Nigeria 1
NO - Norvegia 1
PL - Polonia 1
SA - Arabia Saudita 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 2.151
Città #
Woodbridge 191
Ann Arbor 164
Fairfield 135
Houston 116
Chandler 112
Dublin 89
Jacksonville 83
Frankfurt am Main 77
Ashburn 72
Seattle 51
Dearborn 49
Singapore 45
Wilmington 45
Cambridge 42
New York 38
Princeton 31
Nanjing 28
Hong Kong 22
Altamura 21
Shanghai 17
Lachine 15
Lawrence 15
Hebei 10
Tianjin 10
Beijing 9
Milan 9
Helsinki 8
Jinan 7
San Diego 7
Santa Clara 7
Shenyang 6
Andover 4
Fremont 4
Nanchang 4
Toronto 4
Brussels 3
Changsha 3
Norwalk 3
Taizhou 3
Zhengzhou 3
Boardman 2
Bonndorf 2
Chisinau 2
Chiswick 2
Costa Mesa 2
Hefei 2
Henderson 2
Hounslow 2
Lanzhou 2
Lecco 2
Leicester 2
Los Angeles 2
Monmouth Junction 2
Ottawa 2
Phoenix 2
Redmond 2
Rome 2
San Francisco 2
Tappahannock 2
University Park 2
Varese 2
Bad Bellingen 1
Brookings 1
Chicago 1
Cincinnati 1
City of Westminster 1
Clarks Summit 1
Dallas 1
Erlangen 1
Frisco 1
Fuzhou 1
Goldenstädt 1
Groningen 1
Guangzhou 1
Hangzhou 1
Hendon 1
Huizen 1
Jakarta 1
Jiaxing 1
Kunming 1
Las Vegas 1
Laurel 1
London 1
Madrid 1
Markham 1
Melbourne 1
Melegnano 1
Munich 1
Napoli 1
Ningbo 1
Nürnberg 1
Quito 1
Riyadh 1
Sacramento 1
Segrate 1
Sofia 1
Stockholm 1
São Paulo 1
Taiyuan 1
Tallinn 1
Totale 1.643
Nome #
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 186
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 176
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 159
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 158
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 157
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 156
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 156
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 153
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 143
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 139
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 138
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 137
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 133
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 117
Blunted hepcidin response to oral iron challenge in HFE-hemochromatosis 100
Totale 2.208
Categoria #
all - tutte 6.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020325 0 0 38 32 43 43 50 29 35 22 26 7
2020/2021188 29 15 20 19 13 11 15 12 18 24 5 7
2021/2022157 1 14 1 11 16 12 6 3 13 27 11 42
2022/2023428 63 142 45 25 14 64 0 30 33 4 4 4
2023/2024240 10 10 8 3 31 79 49 5 16 3 3 23
2024/202587 29 52 6 0 0 0 0 0 0 0 0 0
Totale 2.208